Rinella, Erica S <br/><br/>
Efficacy of EGFR inhibition is modulated by model, sex, genetic background and diet: implications for preclinical cancer prevention and therapy trials.  [electronic resource] 

 -  PloS one  2012 
 - e39552 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0039552  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Azoxymethane--toxicity<br/>Colorectal Neoplasms--chemically induced<br/>Diet<br/>Disease Models, Animal<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Phosphorylation<br/>Quinazolines--pharmacology<br/>Sex Factors<br/>Tyrphostins--pharmacology